Roula Younes
Acute Care · Palm Desert, CANPI 1760929897
Payments from drug & device makers
Across 148 payments — averaging $28.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$481
- Johnson & Johnson$439
- Cumberland Pharmaceuticals, Inc.$394
- Paratek Pharmaceuticals, Inc.$363
- La Jolla Pharmaceutical Company$335
- Insmed, Inc.$283
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,10498%
- Education$662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $481 |
| Johnson & Johnson | 24 | $439 |
| Cumberland Pharmaceuticals, Inc. | 23 | $394 |
| Paratek Pharmaceuticals, Inc. | 21 | $363 |
| La Jolla Pharmaceutical Company | 10 | $335 |
| Insmed, Inc. | 8 | $283 |
| Astellas Pharma US Inc | 6 | $243 |
| Merck | 11 | $234 |
| Intuitive Surgical | 1 | $145 |
| Shionogi Inc | 2 | $131 |
| Nevro Corp. | 1 | $125 |
| CSL Behring | 1 | $123 |
| Amgen | 1 | $123 |
| Viiv Healthcare Company | 4 | $113 |
| Smith+Nephew | 3 | $97 |
| Boston Scientific | 1 | $94 |
| Theratechnologies Inc. | 3 | $82 |
| Abbott | 1 | $73 |
| Janssen Products, LP | 1 | $50 |
| Organogenesis Inc. | 2 | $49 |
| Melinta Therapeutics, LLC | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| KCI USA, Inc. | 1 | $24 |
| Mimedx Group, Inc. | 1 | $24 |
| Napo Pharmaceuticals Inc | 1 | $23 |
| Pfizer | 1 | $21 |
| Gilead | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,170 in reported general payments places this provider in the 90th percentile of 1,153 acute care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 13 | $78,465 |
| Daptomycin | 32 | $6,734 |
| Meropenem | 26 | $4,815 |
| ErtapenemErtapenem Sodium | 28 | $4,283 |
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 22 | $2,983 |
| Cefepime Hcl | 18 | $2,702 |
| MicafunginMicafungin Sodium | 20 | $1,611 |
| Fluconazole | 30 | $1,176 |
| CeftriaxoneCeftriaxone Sodium | 18 | $1,109 |
| Doxycycline Hyclate | 19 | $411 |
Paid to pharmacies, not to this prescriber.
Other acute care in Palm Desert
- Leslie PetersenCamarillo$370K
- Joyce KhremianSan Dimas$73K
- Eleanor VierraSacramento$64K
- Frances DyLos Angeles$57K
- Savannah HarrisVentura$56K
- Kori Ann JohnstonLos Angeles$42K
- Caroline KwongOrange$42K
- Gregory KnutzenColton$41K
- Sunita BoparaiLos Angeles$37K
- Sherona BauLos Angeles$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.